ZA200803500B - Pdgf amphiphillic polymer complex - Google Patents

Pdgf amphiphillic polymer complex

Info

Publication number
ZA200803500B
ZA200803500B ZA2008/03500A ZA200803500A ZA200803500B ZA 200803500 B ZA200803500 B ZA 200803500B ZA 2008/03500 A ZA2008/03500 A ZA 2008/03500A ZA 200803500 A ZA200803500 A ZA 200803500A ZA 200803500 B ZA200803500 B ZA 200803500B
Authority
ZA
South Africa
Prior art keywords
amphiphillic
pdgf
polymer complex
polymer
complex
Prior art date
Application number
ZA2008/03500A
Other languages
English (en)
Inventor
Guy Dubreucq
Jose Correia
Remi Soula
Gerard Soula
Correia Latifa Dahri
David Duracher
Olivier Soula
Original Assignee
Adocia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adocia filed Critical Adocia
Publication of ZA200803500B publication Critical patent/ZA200803500B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ZA2008/03500A 2005-09-26 2008-04-21 Pdgf amphiphillic polymer complex ZA200803500B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0509803A FR2891149B1 (fr) 2005-09-26 2005-09-26 Composition pharmaceutique a action cicatrisante comprenant un derive de dextrane soluble et un facteur de croissance derive des plaquettes.
PCT/IB2006/002666 WO2007034320A2 (fr) 2005-09-26 2006-09-26 Complexe polymere amphiphile-pdgf

Publications (1)

Publication Number Publication Date
ZA200803500B true ZA200803500B (en) 2012-09-26

Family

ID=36685952

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA2008/03500A ZA200803500B (en) 2005-09-26 2008-04-21 Pdgf amphiphillic polymer complex
ZA200902008A ZA200902008B (en) 2005-09-26 2009-03-20 Dextran functionalized with hydrophobic amino acids

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA200902008A ZA200902008B (en) 2005-09-26 2009-03-20 Dextran functionalized with hydrophobic amino acids

Country Status (17)

Country Link
US (3) US20070254828A1 (enExample)
EP (2) EP1940449A2 (enExample)
JP (1) JP5438968B2 (enExample)
KR (1) KR101506593B1 (enExample)
CN (3) CN101316607A (enExample)
AU (1) AU2006293613B2 (enExample)
BR (1) BRPI0616439A2 (enExample)
CA (1) CA2623529C (enExample)
DK (1) DK1940448T3 (enExample)
ES (1) ES2406229T3 (enExample)
FR (1) FR2891149B1 (enExample)
IL (1) IL190400A (enExample)
PL (1) PL1940448T3 (enExample)
PT (1) PT1940448E (enExample)
RU (1) RU2424824C2 (enExample)
WO (2) WO2007034321A2 (enExample)
ZA (2) ZA200803500B (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2822834B1 (fr) * 2001-04-02 2005-02-25 Flamel Tech Sa Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation
FR2840614B1 (fr) 2002-06-07 2004-08-27 Flamel Tech Sa Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
FR2843117B1 (fr) * 2002-07-30 2004-10-15 Flamel Tech Sa Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques
FR2860516B1 (fr) * 2003-10-03 2006-01-13 Flamel Tech Sa Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
FR2862536B1 (fr) * 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
FR2914305B1 (fr) * 2007-03-29 2009-07-03 Proteins & Peptides Man Dextran fonctionnalise par des amino-acides hydrophobes.
US20120041079A1 (en) * 2006-09-26 2012-02-16 Adocia Dextran functionalized by hydrophobic amino acids
FR2908414B1 (fr) 2006-11-13 2012-01-20 Centre Nat Rech Scient Immobilisation de proteines membranaires sur un support par l'intermediaire d'une molecule amphiphile
KR20150072458A (ko) 2006-11-15 2015-06-29 코다 테라퓨틱스, 인크. 상처 치유를 위한 개선 방법 및 조성물
FR2914191A1 (fr) * 2007-03-29 2008-10-03 Proteins & Peptides Man Composition angiogenique.
FR2919188B1 (fr) * 2007-07-27 2010-02-26 Proteins & Peptides Man Complexes entre un polymere amphiphile et une proteine osteogenique appartenant a la famille des bmps
KR20110014588A (ko) * 2008-04-14 2011-02-11 아도시아 성장인자/양친매성 중합체 복합체, 가용성 양이온 염 및 유기 지지체를 포함하는 골형성 조성물
FR2934999B1 (fr) * 2008-08-13 2011-07-29 Adocia Polysaccharides fonctionnalises par des derives du tryptophane
BRPI0913684A2 (pt) * 2008-09-26 2015-10-20 Adocia complexo composto por um polissacarídeo substituído por um triptofano ou um derivado de triptofano a partir de uma proteína ligadora à heparina, composição farmacêutica e seus usos
US8426382B2 (en) * 2008-10-06 2013-04-23 Adocia Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivative
FR2936800B1 (fr) * 2008-10-06 2010-12-31 Adocia Polysaccharide comportant des groupes fonctionnels carboxyles substitues par un derive d'alcool hydrophobe
US9018190B2 (en) 2009-03-27 2015-04-28 Adocia Functionalized oligosaccharides
FR2943538B1 (fr) * 2009-03-27 2011-05-20 Adocia Formulation a action rapide d'insuline recombinante humaine
FR2958646B1 (fr) * 2010-04-07 2012-05-18 Adocia Polysaccharides comportant des groupes fonctionnels carboxyles substitues par un derive d'acide hydrophobe.
JP5950458B2 (ja) * 2010-02-09 2016-07-13 アドシア 少なくとも３価のスペーサーにより保有される少なくとも２つの疎水性基により官能化されたアニオン性多糖類
FR2966248B1 (fr) 2010-10-18 2020-05-01 Centre National De La Recherche Scientifique (Cnrs) Procede de fonctionnalisation de surfaces pour la detection d'analytes
WO2012153071A2 (fr) * 2011-05-10 2012-11-15 Adocia Polysaccharides à degré de fonctionnalisation modulable
US20130231281A1 (en) 2011-11-02 2013-09-05 Adocia Rapid acting insulin formulation comprising an oligosaccharide
KR101466511B1 (ko) * 2012-11-12 2014-11-27 성균관대학교산학협력단 저산소증 관련 질환의 진단 및 치료용 저산소 감응형 나노입자
KR102367083B1 (ko) 2012-11-13 2022-02-24 아도시아 치환된 음이온성 화합물을 포함하는 속효성 인슐린 제형
CN104903341B (zh) * 2012-11-13 2020-04-21 阿道恰公司 由离散数个糖单元组成的骨架组成的经取代阴离子化合物
US9795678B2 (en) 2014-05-14 2017-10-24 Adocia Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
FR3020947B1 (fr) 2014-05-14 2018-08-31 Adocia Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations
EP4491184A3 (en) 2014-08-22 2025-03-26 Auckland Uniservices Limited Channel modulators
FR3025428A1 (fr) * 2014-09-08 2016-03-11 Adocia Composition pharmaceutique stable comprenant du pdgf
FR3043557B1 (fr) 2015-11-16 2019-05-31 Adocia Composition a action rapide d'insuline comprenant un citrate substitue
CN106188649B (zh) * 2016-07-04 2019-06-25 宁波国际材料基因工程研究院有限公司 一种药物缓释载体水凝胶及其制备方法
CN111171174B (zh) * 2020-01-14 2022-02-01 上海图珐医药科技有限公司 葡聚糖衍生物及其制备方法和用于制备药剂的附加剂
CN111253569B (zh) * 2020-02-26 2021-06-01 山东大学 一种聚合物、其制剂及其制备方法和应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US169120A (en) * 1875-10-26 Improvement in machines for bending scythe-snaths
US183282A (en) * 1876-10-17 Improvement in striping implements
US2808405A (en) * 1955-03-11 1957-10-01 Ohio Commw Eng Co Acylated amino acid esters of dextran products and method of making same
US4766073A (en) 1985-02-25 1988-08-23 Zymogenetics Inc. Expression of biologically active PDGF analogs in eucaryotic cells
US4717717A (en) 1986-11-05 1988-01-05 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
US5705485A (en) * 1987-09-18 1998-01-06 Ethicon, Inc. Gel formulations containing growth factors
US5457093A (en) * 1987-09-18 1995-10-10 Ethicon, Inc. Gel formulations containing growth factors
DE69102651T2 (de) * 1990-07-23 1994-10-06 Zymogenetics, Inc., Seattle, Wash. Proteaseresistenter pdgf und dessen verwendungen.
US5234908A (en) * 1991-04-12 1993-08-10 Creative Biomolecules, Inc. Method of treating gastrointestinal ulcers with platelet derived growth factor
JPH0543453A (ja) * 1991-08-20 1993-02-23 Sumitomo Pharmaceut Co Ltd 創傷治癒促進用局所用徐放性製剤
WO1993008825A1 (en) 1991-11-04 1993-05-13 Zymogenetics, Inc. Pdgf gel formulation
DE4136324A1 (de) * 1991-11-05 1993-05-13 Hoechst Ag Dextranderivate als adsorptionsmittel fuer gallensaeuren, mit gallensaeuren beladene dextranderivate und verfahren zu deren herstellung sowie deren anwendung als arzneimittel
GB9301258D0 (en) * 1993-01-22 1993-03-17 Courtaulds Plc Use of absorbent fibre
US5612321A (en) * 1995-06-22 1997-03-18 Hercules Incorporated Antioxidant grafted polysaccharides
CA2192725C (en) * 1995-12-28 2004-04-20 Kenji Tsujihara Camptothecin derivatives
EP0948538B1 (en) 1996-12-13 2008-06-11 Novartis Vaccines and Diagnostics, Inc. Analysis and separation of platelet-derived growth factor proteins
AU7466998A (en) * 1997-04-14 1998-11-11 Byron E. Anderson Method and material for inhibiting complement
FR2772382B1 (fr) * 1997-12-11 2000-03-03 Solutions Derives de dextrane, leur procede de preparation et leurs applications comme medicaments a action biologique specifique
FR2794649B1 (fr) * 1999-06-11 2003-04-11 Solutions Biomateriau a base d'un derive de dextrane insolubilise et d'un facteur de croissance, son procede de preparation et ses applications
FR2794976B1 (fr) * 1999-06-16 2004-05-07 Solutions Compositions pharmaceutiques a action cicatrisante ou anti-complementaire comprenant un derive de dextrane
JP4434584B2 (ja) * 2001-01-26 2010-03-17 ジェネティックス ファーマシューティカルズ， インク． 血管新生を促進する方法及び組成物
DE10140623A1 (de) * 2001-08-18 2003-03-06 Nawa Heilmittel Gmbh Pharmazeutisches Präparat zur Behandlung von Wunden
US7368125B2 (en) * 2002-06-05 2008-05-06 Ethicon, Inc. Amphiphilic polymers for medical applications
FR2840614B1 (fr) * 2002-06-07 2004-08-27 Flamel Tech Sa Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
CN1506113A (zh) * 2002-12-09 2004-06-23 北京金赛狮生物制药技术开发有限责任 重组血小板源生长因子水凝胶制剂的制备方法
CN1506112A (zh) * 2002-12-09 2004-06-23 北京金赛狮生物制药技术开发有限责任 重组血小板源生长因子的水凝胶制剂
CN1508259A (zh) * 2002-12-19 2004-06-30 北京金赛狮生物制药技术开发有限责任 重组人血小板源生长因子的发酵方法
CA2720312A1 (en) 2004-01-30 2005-08-18 Euro-Celtique S.A. Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
WO2007013100A1 (en) 2005-07-26 2007-02-01 Virchow Biotech Private Limited Gel formulation comprising platelet derived growth factor
CA2648395A1 (fr) 2006-04-07 2007-10-18 Adocia Polysaccharides bifonctionnalises

Also Published As

Publication number Publication date
PT1940448E (pt) 2013-04-15
WO2007034320A3 (fr) 2007-10-04
EP1940448A2 (fr) 2008-07-09
WO2007034321A3 (fr) 2007-10-04
RU2008116585A (ru) 2009-11-10
RU2424824C2 (ru) 2011-07-27
EP1940448B1 (fr) 2013-03-06
CN103203023A (zh) 2013-07-17
ZA200902008B (en) 2010-09-29
FR2891149B1 (fr) 2007-11-30
ES2406229T3 (es) 2013-06-06
JP2009509952A (ja) 2009-03-12
JP5438968B2 (ja) 2014-03-12
KR101506593B1 (ko) 2015-03-30
US20090221805A1 (en) 2009-09-03
WO2007034320A2 (fr) 2007-03-29
AU2006293613B2 (en) 2012-05-17
CN101631804B (zh) 2012-11-28
CA2623529C (fr) 2013-12-24
CN101316607A (zh) 2008-12-03
AU2006293613A1 (en) 2007-03-29
CN103203023B (zh) 2016-06-01
US8241620B2 (en) 2012-08-14
US20070254828A1 (en) 2007-11-01
US20110301086A1 (en) 2011-12-08
CN101631804A (zh) 2010-01-20
IL190400A (en) 2015-08-31
WO2007034321A2 (fr) 2007-03-29
PL1940448T3 (pl) 2013-08-30
CA2623529A1 (fr) 2007-03-29
FR2891149A1 (fr) 2007-03-30
KR20080080278A (ko) 2008-09-03
DK1940448T3 (da) 2013-06-03
BRPI0616439A2 (pt) 2011-06-21
EP1940449A2 (fr) 2008-07-09

Similar Documents

Publication Publication Date Title
ZA200803500B (en) Pdgf amphiphillic polymer complex
EG27143A (en) Biostatic polymer
ZA200808637B (en) Polymers
GB0724001D0 (en) Crosslinkable polymer compositions
PL2027208T3 (pl) Amfifilowe kopolimery blokowe
GB0418581D0 (en) Polymer composition
EP2077028A4 (en) WITH NAME INQUIRY ACTIVATED ZONES
EP2053069A4 (en) HYDROPHILIC POLYMER
GB0526186D0 (en) Arylamine polymer
GB0517085D0 (en) Polymer prosthesis
BRPI0606959A2 (pt) mescla polimérica
GB0423212D0 (en) Polymer
EP2026825A4 (en) FURANON-INITIATED POLYMERS
GB2448098B (en) Block copolymer
AU2006326855A8 (en) Polymer blends
ZA200707710B (en) Multiple function graft polymer
GB0506146D0 (en) Polymer processing
GB0604911D0 (en) Polymers
GB0512468D0 (en) Improved pulleys
EP1856189A4 (en) ANTISTATIC AGENT FOR POLYMERS
PL2041192T3 (pl) Kopolimer z grupami bezwodnikowymi
GB0608020D0 (en) Sheeting
GB0400612D0 (en) Polymer solutions
GB0500898D0 (en) Gold-protein coagulation
GB0522175D0 (en) Polymers